The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Dar Bioscience, Inc.(NASDAQ:DARE) 
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The company intends to develop therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical ...
Website: http://www.darebioscience.com
Founded: 2015
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology
Dar Bioscience . Days Payable Outstanding ttm (DPO)
Dar Bioscience . Days Receivable Outstanding ttm (DSO)
Dar Bioscience . Days Inventory Outstanding ttm (DIO)
Dar Bioscience . Op Cashflow Per Share ttm
Dar Bioscience . Free Cashflow Per Share ttm
Dar Bioscience . Cash Per Share ttm
Dar Bioscience . P/S ratio ttm
Dar Bioscience . (GAAP) P/E ratio ttm
Dar Bioscience . P/B ratio ttm
No extra charts and metrics for this ticker.